Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 431,875
  • Shares Outstanding, K 38,219
  • Annual Sales, $ 210,780 K
  • Annual Income, $ 65,630 K
  • EBIT $ -122 M
  • EBITDA $ -128 M
  • 60-Month Beta -0.12
  • Price/Sales 7.68
  • Price/Cash Flow 6.93
  • Price/Book 1.23

Options Overview Details

View History
  • Implied Volatility 238.74% (+2.97%)
  • Historical Volatility 50.66%
  • IV Percentile 39%
  • IV Rank 17.80%
  • IV High 1,251.56% on 09/10/25
  • IV Low 19.44% on 09/09/25
  • Expected Move (DTE 29) 0.94 (8.35%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 50
  • Volume Avg (30-Day) 36
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 717
  • Open Int (30-Day) 784
  • Expected Range 10.36 to 12.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.06
  • Number of Estimates 3
  • High Estimate -0.93
  • Low Estimate -1.14
  • Prior Year 0.03
  • Growth Rate Est. (year over year) -3,633.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.33 +21.11%
on 01/12/26
11.49 -1.65%
on 01/16/26
+0.32 (+2.91%)
since 12/19/25
3-Month
6.09 +85.55%
on 11/06/25
11.55 -2.16%
on 12/18/25
+4.94 (+77.67%)
since 10/21/25
52-Week
4.93 +129.21%
on 08/11/25
14.27 -20.81%
on 02/05/25
-1.76 (-13.48%)
since 01/21/25

Most Recent Stories

More News
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

-- Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 – -- Expects to initiate global Phase 1/2 MAD clinical...

TRDA : 11.30 (+6.40%)
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that Dipal Doshi, Chief Executive Officer, will deliver a company presentation at the 44 th Annual...

TRDA : 11.30 (+6.40%)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 40,650 restricted stock units (“RSUs”) and options to...

TRDA : 11.30 (+6.40%)
Entrada Therapeutics Reports Third Quarter 2025 Financial Results

-- Company on track to report ELEVATE-44-201 data from first patient cohort in Q2 2026 -- -- First patient dosed in ELEVATE-45-201 and the Company is on track to report data from the first patient...

TRDA : 11.30 (+6.40%)
Entrada Therapeutics to Present at Upcoming Investor Conferences

BOSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the Company will participate in two upcoming investor conferences. Jefferies Global Healthcare...

TRDA : 11.30 (+6.40%)
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program

-- The 2025 DREAMS Grant Program awards $50,000 each to two non-profit organizations working to advance equity, accessibility and inclusion for those living with Duchenne in the U.S., EU or U.K. -- ...

TRDA : 11.30 (+6.40%)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 54,360 restricted stock units (“RSUs”) and options to...

TRDA : 11.30 (+6.40%)
Entrada Therapeutics Reports Second Quarter 2025 Financial Results

-- First patient dosed in ELEVATE-44-201 with data from first patient cohort anticipated in H1 2026 -- -- Initiated ELEVATE-45-201 and on track to dose the first patient in Q3 2025 -- -- Multiple...

TRDA : 11.30 (+6.40%)
Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors

TRDA : 11.30 (+6.40%)
BIIB : 172.62 (+4.38%)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TRDA : 11.30 (+6.40%)

Business Summary

Entrada Therapeutics Inc. is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles(TM) to engage intracellular targets. Entrada Therapeutics Inc. is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 12.40
2nd Resistance Point 11.91
1st Resistance Point 11.61
Last Price 11.30
1st Support Level 10.81
2nd Support Level 10.32
3rd Support Level 10.02

See More

52-Week High 14.27
Last Price 11.30
Fibonacci 61.8% 10.70
Fibonacci 50% 9.60
Fibonacci 38.2% 8.50
52-Week Low 4.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar